US DOE Approval Boosts Oklo's Groves Reactor Milestone

Key Facts

In a boost for advanced nuclear energy in the United States, the U.S. Department of Energy approved the Documented Safety Analysis for Oklo's Groves Isotope Test Reactor, lifting the company's stock. The approval is a key regulatory milestone ahead of the reactor's planned criticality in July.

The achievement comes amid accelerating efforts to develop small modular reactors in the U.S., as Oklo seeks to solidify its position as a leading next-generation nuclear player. Analysts view the approval as strengthening the reactor design's credibility and bringing the company closer to commercial operation, especially given Washington's focus on clean energy and supply security.

Following this approval, markets are watching for the criticality test expected in July as a pivotal event to evaluate reactor performance. The company also awaits further regulatory decisions from the Nuclear Regulatory Commission that could open the door to broader deployment of small nuclear power. Oklo stock (OKLO) remains a focus for clean-energy investors as regulatory developments unfold.

Version History